[1] Zhuang, X., Shi, S., Liu, S., Jiao, Y., Huang, B., Yang, Y., Yang, L., Yang, X., Wang, H., Liang, C., Song, D., Yu, H., Zou, D., Sun, Q., Yang, S., Yin, C., Li, J., Liu, Y., Min, J., … Chu, B. (2025). Dipyridamole Acts as Clinical Ferroptosis Inhibitor to Prevent from Tissue Injury. Advanced Science, 12 23. https://doi.org/10.1002/advs.202500566
[2] Ming-Ming Zheng. (2025). IMPDH inhibitors upregulate PD-L1 in cancer cells without impairing immune checkpoint inhibitor efficacy. Acta Pharmacologica Sinica, 1058–1067. https://doi.org/10.1038/s41401-024-01411-8
[3] Qiang Zhang. (2025). Targeting both the enzymatic and non-enzymatic functions of DHODH as a therapeutic vulnerability in c-Myc-driven cancer. Cell Reports, 44 3, 115327. https://doi.org/10.1016/j.celrep.2025.115327
[4] Niu, X., Wang, Bodong, Zhao, A., Yang, W., Li, N., Shi, W., Lei, W., Cheng, Y., Wang, Baoying, Yang, Y., Wu, S., & Tian, Y. (2025). Pleiotropic role of mGluR7/MAPK signaling in the protection of intelectin-1 against cerebral ischemia-reperfusion injury. Pharmacological Research, 216, Article 107735. https://doi.org/10.1016/j.phrs.2025.107735
[5] Zeng, X., Shi, C., Han, Y., Hu, K., Li, Xiaoqing, Wei, C., Ding, L., Cui, J., Huang, S., Xu, Y., Zhang, M., Shan, W., Luo, Q., Yu, J., Zheng, Z., Li, Xia, Qian, P., & Huang, H. (2024). A metabolic atlas of blood cells in young and aged mice identifies uridine as a metabolite to rejuvenate aged hematopoietic stem cells. Nature Aging, 4 10, 1477–1492. https://doi.org/10.1038/s43587-024-00669-1
United States
